Characterization of a neutralizing monoclonal antibody directed at variable domain I of the major outer membrane protein of Chlamydia trachomatis C-complex serovars
Authors:
- 1 April 1993
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 61 (4) , 1365-70
Abstract
A monoclonal antibody (MAb), C10, that neutralized in vitro the infectivity of serovars C, I, J, and L3 (members of the C and C-related complexes) of Chlamydia trachomatis was identified. Of the 15 major serovars and the mouse pneumonitis strain of C. trachomatis, Chlamydia psittaci, and Chlamydia pneumoniae, which were used as nontreated and heat-treated (56 degrees C, 30 min) antigens in a dot blot assay, only serovars C, I, J, and L3 were recognized with both the native and treated antigens. Western blot (immunoblot) results showed that MAb C10 recognized the major outer membrane protein of these four serovars. Overlapping hexameric peptides corresponding to variable domains (VDs) I, II, III, and IV of the major outer membrane protein of C. trachomatis serovar C were synthesized, and peptide screening showed that MAb C10 mapped to the VD I amino acid sequence VAGLQNDPT. Results of an in vitro neutralization assay correlated with those of the indirect immunofluorescence assay, Western blot, and dot blot assay in that only serovars C, I, J, and L3 were neutralized by MAb C10. In vitro competitive neutralization experiments, using a peptide representing VD I of serovar C to compete with C. trachomatis serovar C for MAb C10 binding, revealed that both serological and neutralizing activities of MAb C10 were inhibited by the VD I peptide. In an in vivo toxicity/infectivity assay using serovar L3 pretreated with MAb C10, there was 100% survival of mice infected with a lethal dose at 48 h. In contrast, the control group, consisting of mice injected with the same dose of L3 pretreated with a MAb that does not recognize L3, had no survivors during a 48-h observation period. In summary, since the surface-exposed contiguous epitope recognized by MAb C10 binds neutralizing antibodies that are subspecies specific for the C and C-related complexes, it should be considered for inclusion in the development of a chlamydial vaccine.Keywords
This publication has 14 references indexed in Scilit:
- Immunogenicity of a chimeric peptide corresponding to T helper and B cell epitopes of the Chlamydia trachomatis major outer membrane protein.Journal of Experimental Medicine, 1992
- Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis.Journal of Experimental Medicine, 1990
- Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes.Proceedings of the National Academy of Sciences, 1988
- High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis.Journal of Experimental Medicine, 1988
- Cognitive features of continuous antigenic determinantsJournal of Molecular Recognition, 1988
- Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDaAnalytical Biochemistry, 1987
- Strategies for epitope analysis using peptide synthesisJournal of Immunological Methods, 1987
- Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis.The Journal of Immunology, 1987
- Cellular Immunity to the Mouse Pneumonitis AgentThe Journal of Infectious Diseases, 1984
- Trachoma Vaccine Studies in MonkeysAmerican Journal of Ophthalmology, 1967